|
CAMSAP1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.410100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.859900E-03 |
| Normal-vs-Stage2 |
1.157990E-01 |
| Normal-vs-Stage3 |
8.492000E-01 |
| Normal-vs-Stage4 |
6.913000E-01 |
| Stage1-vs-Stage2 |
9.184600E-01 |
| Stage1-vs-Stage3 |
6.368300E-02 |
| Stage1-vs-Stage4 |
1.091010E-01 |
| Stage2-vs-Stage3 |
1.955420E-01 |
| Stage2-vs-Stage4 |
3.019400E-01 |
| Stage3-vs-Stage4 |
7.388000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.525700E-02 |
| Normal-vs-AfricanAmerican |
5.900300E-02 |
| Normal-vs-Asian |
1.297620E-01 |
| Caucasian-vs-AfricanAmerican |
8.852400E-01 |
| Caucasian-vs-Asian |
8.540600E-01 |
| AfricanAmerican-vs-Asian |
8.792400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.618900E-04 |
| Normal-vs-Female |
4.300400E-01 |
| Male-vs-Female |
1.464270E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.574400E-01 |
| Normal-vs-Extreme_Weight |
5.063100E-03 |
| Normal-vs-Obese |
4.943400E-01 |
| Normal-vs-Extreme_Obese |
5.584200E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.760600E-01 |
| Normal_Weight-vs-Obese |
7.330600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.324800E-01 |
| Extreme_Weight-vs-Obese |
9.094200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.328000E-01 |
| Obese-vs-Extreme_Obese |
1.886810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.818000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.554200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.000700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.040850E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.067990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.278300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.583200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.097700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.064200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.635190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.106050E-02 |
| Normal-VS-Type2 PRCC |
2.379700E-02 |
| Normal-VS-KIRP CIMP |
6.442300E-02 |
| Normal-VS-Unclassified PRCC |
3.094000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.890400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.266200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.203400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.622300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.172800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.507800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.409850E-04 |
| Normal-vs-N1 |
1.916000E-01 |
| Normal-vs-N2 |
5.843600E-01 |
| N0-vs-N1 |
4.335800E-03 |
| N0-vs-N2 |
2.999700E-02 |
| N1-vs-N2 |
9.390400E-01 |
|
|
